Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Glenmark Pharmaceuticals Europe Limited, Laxmi House, 2B Draycott Avenue, Kenton, Middlesex, HA3 0BU, United Kingdom
Ursodeoxycholic acid 150 mg tablets.
| Pharmaceutical Form |
|---|
|
Tablet. Ursodeoxycholic acid 150 mg Tablets: White to off-white, round shaped uncoated tablets approximately 9.50 mm in size with breakline and “G” “442” engraved on one side and plain on the other side. The tablet can be divided into equal doses. |
Each Ursodeoxycholic acid 150 mg Tablet contains 150 mg of ursodeoxycholic acid (UDCA).
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Ursodeoxycholic acid |
The ursodeoxycholic acid converts lithogenic bile in non-lithogenic bile and gradually dissolves the cholesterol gallstones. |
| List of Excipients |
|---|
|
Cellulose microcrystalline (Microcel 101) (E460) |
Clear PVC/PVDC – plain aluminium foil.
Pack size: 20, 30, 50, 60 and 100 tablets.
Not all pack sizes may be marketed.
Glenmark Pharmaceuticals Europe Limited, Laxmi House, 2B Draycott Avenue, Kenton, Middlesex, HA3 0BU, United Kingdom
PL 25258/0266
Date of first authorization: 21/05/2018
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
